RGT Wealth Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-900
Closed -$93K 239
2021
Q4
$93K Buy
+900
New +$104K 0.01% 113
2021
Q1
Sell
-2,084
Closed -$244K 65
2020
Q4
$244K Buy
+2,084
New +$229K 0.05% 57

Other funds holding MDT

RGT Wealth Advisors's MDT Position: Q1 2022 in Review

RGT Wealth Advisors sold out of Medtronic (MDT) in Q1 2022, closing a stake of 900 shares — an estimated $93K sold.

RGT Wealth Advisors first reported a position in MDT in Q4 2020 and held it in 2 quarters. The position peaked at $244K in Q4 2020. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • RGT Wealth Advisors reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
  • RGT Wealth Advisors sold 900 Medtronic shares in Q1 2022, an estimated $93K.
  • RGT Wealth Advisors first reported a position in Medtronic in Q4 2020 and held it in 2 quarters.
  • RGT Wealth Advisors's Medtronic position peaked at $244K in Q4 2020.
  • 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on RGT Wealth Advisors's 13F filing for Q1 2022, filed 5 May 2022.